• Molecular NameSulfisoxazole
  • SynonymSulfadimethylisoxazole; Sulfafurazol; Sulfafurazole; Sulfaisoxazole; Sulfasoxazole; Sulfisonazole; Sulfisoxasole; Sulfisoxazol; Sulfisoxazole Dialamine; Sulfisoxazole Diolamine; Sulfofurazole; Sulphafurazol; Sulphafurazole; Sulphafurazolum; Sulphaisoxazole; Sulphisoxazol; Sulphofurazole
  • Weight283.376
  • Drugbank_IDDB00263
  • ACS_NO127-69-5
  • Show 3D model
  • LogP (experiment)1.01
  • LogP (predicted, AB/LogP v2.0)1.82
  • pka5
  • LogD (pH=7, predicted)1.81
  • Solubility (experiment)0.13 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-2.55
  • LogSw (predicted, AB/LogsW2.0)0.63
  • Sw (mg/ml) (predicted, ACD/Labs)0.72
  • No.of HBond Donors3
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds3
  • TPSA121.7
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin or phenazopyridine. It is used locally in a 4% solution or ointment.
  • Absorption_value95.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability96.0
  • Protein binding91.4
  • Volume of distribution (VD)0.1~ 0.2 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life4~7 h
  • ExcretionExcreted unchanged in urine
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityLD50=6800 mg/kg (Orally in mice)
  • LD50 (rat)N/A
  • LD50 (mouse)N/A